polycythemia vera (pv)
Showing 1 - 6 of 6
Ruxolitinib for Polycythemia Vera in Patients Resistant to or
Completed
- Polycythemia Vera (PV)
- Ruxolitinib
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))
Recruiting
- Polycythemia Vera (PV)
- P1101 (Ropeginterferon alfa-2b)
-
Toon-shi, Ehime, Japan
- +5 more
Jun 13, 2022
Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)
Active, not recruiting
- Polycythemia Vera (PV)
- Essential Thrombocythemia (ET)
-
Mannheim, Baden-Württemberg, Germany
- +23 more
Oct 6, 2020
Myeloproliferative Tumors (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Toronto (Upper gastrointestinal
Completed
- Myeloproliferative Neoplasms (MPN)
- +3 more
- Upper gastrointestinal endoscopy and Doppler ultrasound
-
Toronto, Ontario, Canada
- +1 more
Dec 12, 2019